Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2005

01-07-2005

BMI-1 is Highly Expressed in M0-Subtype Acute Myeloid Leukemia

Authors: Masashi Sawa, Kazuhito Yamamoto, Toshiya Yokozawa, Hitoshi Kiyoi, Asahi Hishida, Tomohiro Kajiguchi, Masao Seto, Akio Kohno, Kunio Kitamura, Yoshie Itoh, Norio Asou, Nobuyuki Hamajima, Nobuhiko Emi, Tomoki Naoe

Published in: International Journal of Hematology | Issue 1/2005

Login to get access
Metadata
Title
BMI-1 is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
Authors
Masashi Sawa
Kazuhito Yamamoto
Toshiya Yokozawa
Hitoshi Kiyoi
Asahi Hishida
Tomohiro Kajiguchi
Masao Seto
Akio Kohno
Kunio Kitamura
Yoshie Itoh
Norio Asou
Nobuyuki Hamajima
Nobuhiko Emi
Tomoki Naoe
Publication date
01-07-2005
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2005
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.05013

Other articles of this Issue 1/2005

International Journal of Hematology 1/2005 Go to the issue

OriginalPaper

A Novel Mutation in the Juxtamembrane Intracellular Sequence of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Gene in a Patient with Severe Congenital Neutropenia Augments G-CSF Proliferation Activity but Not through the MAP Kinase Cascade

OriginalPaper

Runx1/AML1 in Normal and Abnormal Hematopoiesis

Case Report

Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita: Report of a Case

Case Report

Identification of a Chromosomal Breakpoint and Detection of a Novel Form of an MLL- AF17 Fusion Transcript in Acute Monocytic Leukemia with t(11;17)(q23;q21)

OriginalPaper

NUP98 Fusion in Human Leukemia: Dysregulation of the Nuclear Pore and Homeodomain Proteins

OriginalPaper

Comparison of 2 Preparative Regimens for Stem Cell Transplantation from HLA-Matched Sibling Donors in Patients with Advanced Myelodysplastic Syndrome
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits